Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-12-01

著者

• ITOH Kuniaki

  Division of Oncology and Hematology, National Cancer Center Hospital East

• Minami Hironobu

  Division Of Oncology/hematology National Cancer Center Hospital East

• Minami H

  Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine

• Minami Hironobu

  神戸大学 医学研究科腫瘍内科学

• Minami Hironobu

  名古屋第一赤十字病院

• Minami Hironobu

  National Cancer Center Hospital East

• Minami H

  Department Of Hematology Fujita Health University School Of Medicine

• Mukai Hirofumi

  国立がんセンター東病院 化学療法科血液

• Mukai Hirofumi

  Division Of Oncology/hematology National Cancer Center Hospital East

• Itoh Kuniaki

  National Cancer Center Hospital East Oncology/hematology

• Mukai Hirofumi

  National Cancer Center Hospital East Oncology/hematology

• NAGAI Shunji

  National Cancer Center Hospital East, Oncology/Hematology

• Minami Hironobu

  The Division Of Oncology/hematology National Cancer Center Hospital East

• Minami Hironobu

  Oncology/hematology National Cancer Center Hospital East

• Nagai Shunji

  National Cancer Center Hospital East Oncology/hematology

• Minami Hironobu

  National Cancer Center Hospital East Oncology/hematology

• Itoh Kuniaki

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• NAGAI Shunji

  Division of Oncology/Hematology, National Cancer Center Hospital East

• MATSUBARA Nobuaki

  Division of Oncology and Hematology, National Cancer Center Hospital East

• Mukai Hirofumi

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Matsubara Nobuaki

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Itoh Kuniaki

  Division of Hematology and Oncology, National Cancer Center Hospital East

• NAGAI Shunji

  Division of Oncology and Hematology, National Cancer Center Hospital East

関連論文

• Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
• Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
• 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
• Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
• Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
• Genetic Polymorphisms of UGT1A6 in a Japanese Population
• Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
• Three Novel Single Nucleotide Polymorphisms in UGT1A9
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
• Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Three novel single nucleotide polymorphisms in UGT1A10
• Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
• Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
• Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
• Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
• Extragonadal germ cell tumors in Japan
• Treatable Subsets in Cancer of Unknown Primary Origin
• Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
• Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
• A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
• Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
• Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
• Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
• Treatment strategy for HER2-positive breast cancer
• Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
• P-39 2'-DEXY-4'-C-ETHYNYL-2-FLUOROADENOSINE, A NRTI THAT COULD BE AN IDEAL DRUG FOR BOTH HIV-AND HBV-INFECTIONS
• Synthesis of the L-Enantiomer of 4'-C-Ethynyl-2'-deoxycytidine(Organic Chemistry)
• Micafungin-induced immune hemolysis attacks
• Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
• Prognostic Factors for Short-term Survival in Patients with Stage IV Non-small Cell Lung Cancer
• Pharmacokinetic Study of Carboplatin Given on a 5-Day Intravenous Schedule
• Therapeutic Drug Monitoring in 21-Day Oral Etoposide Treatment for Lung Cancer
• Therapeutic Drug Monitoring of Etoposide in a 14-Day Infusion for Non-small-cell Lung Cancer
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
• Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
• Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
• Occult Thymic Carcinoma Presenting as Malignant Cardiac Tamponade
• Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
• Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Chemical Identity of a Rotting Animal-Like Odor Emitted from the Inflorescence of the Titan Arum (Amorphophallus titanum)
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
• Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
• Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
• Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
• Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
• Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
• Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
• Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
• Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
• Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
• Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
• Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
• Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
• Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
• Orbital MALT Lymphoma, Abdominal Hodgkin lymphoma, and Systemic Diffuse Large B-cell Lymphoma Develop Sequentially in One Patient
• Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
• Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
• Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer : a new risk model for success from an analysis of 75 cases

もっと見る 閉じる

スポンサーリンク